Manulife (Manufacturers Life Insurance)’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,275	Closed	-$86K	–	3339
2021 Q1	$86K	Sell	3,275 -136	-4%	-$6.18K	﹤0.01%	3053
2020 Q4	$123K	Buy	3,411 +469	+16%	+$17K	﹤0.01%	2920
2020 Q3	$104K	Buy	2,942 +884	+43%	+$38.4K	﹤0.01%	2792
2020 Q2	$86K	Buy	+2,058	New	+$139K	﹤0.01%	2796

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s EVFM Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2021, closing a stake of 3,275 shares — an estimated $86K sold.

Manulife (Manufacturers Life Insurance) first reported a position in EVFM in Q2 2020 and held it in 4 quarters. The position peaked at $123K in Q4 2020. 81 funds tracked by Wall St. Rank hold EVFM as of Q2 2021.

Manulife (Manufacturers Life Insurance) reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 3,275 Evofem Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $86K.
Manulife (Manufacturers Life Insurance) first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Manulife (Manufacturers Life Insurance)'s Evofem Biosciences, Inc. Common Stock position peaked at $123K in Q4 2020.
81 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.